PETER LYNCH’S FAVORITE METRIC IS THE PEG RATIO PEG < 1 usually means mispriced growth PEG > 2 starts to push into the danger zone Semiconductor multi-year PEG ratios: • $INTC ~3.2x • $AMAT ~2.5x • $KLAC ~2.5x • $ARM ~2.2x • $ALAB ~2.1x • $ANET ~2.0x • $LRCX ~2.0x • $AAOI ~1.6x • $ASML ~1.6x • $COHR ~1.4x • $CRDO ~1.1x • $NVDA ~0.9x • $TSM ~0.9x • $AVGO ~0.9x • $AMD ~0.8x • $SNDK ~0.7x • $ON ~0.7x • $MRVL ~0.6x • $LITE ~0.6x • $MU ~0.2x
Buy or sell guide
Should I Buy LRCX Stock Right Now?
A fast read on Wall Street conviction, live analyst commentary on X, and current valuation context for Lam Research Corporation.
Updated 2026-05-06
Wall Street currently rates LRCX buy with a 12-month price target of $291 (-2.2% downside). See live commentary from high-reach stock analysts on X, plus the bull case, key risks, and the latest earnings execution.
Wall Street
Buy50 analystsConsensus target
$291 target (-2.2%)Current price $297.17Analyst sentiment
Bearish from 1 recent analyst posts0 bull · 1 bear · 0 neutralEarnings context
EPS beat 8.1%Reported Wed Apr 22Wall Street verdict
Should I Buy LRCX Stock? Here's What Analysts Think
50 analysts currently cover LRCX. Below is their consensus rating, price target range, and implied upside.
According to 50 analysts, Lam Research Corporation (LRCX) is rated Buy with a consensus 12-month price target of $291 — representing 2% downside from today's price of $297. The bull case target is $385, the bear case is $200.
LRCXBuy
From 50 analyst ratings- Current price
- $297.17
- Consensus Target
- $291 (-2.2% downside)
- Forward P/E
- 52.6x
- Coverage
- 50 analyst ratings
High target$385
Low target$200
At $297.17, the consensus setup implies -2.2% versus the 12-month target.
- 38 of 50 analysts lean Buy or Strong Buy, while 11 stay on Hold and 1 lean bearish.
- LRCX trades at roughly 52.6x forward earnings, so the bull case still depends on growth staying strong.
- Analysts span a wide range from $200 to $385, so conviction matters as much as the consensus target.
Below, compare that institutional answer with the live analyst commentary on X for LRCX right now.
11 of 13 analysts raised targetsJP Morgan $315RBC Capital $310TD Cowen $340+5 more
May 2026Live commentary on X· Last 30 days · 1 take
What Analysts Are Saying About Lam Research Corporation Right Now
Real posts from high-reach stock analysts mentioning LRCX, shown exactly as written. Sorted by engagement — most discussed first.
Recent high-reach analyst commentary leans bearish — the market conversation is pushing back on the long thesis.
Bearish·
0 Bullish0 Neutral1 Bearish
Posts sourced from high-follower stock analysts on X. Bullish/bearish signals are auto-classified; verify on the original post before acting.
Should you buy LRCX?
Is LRCX a Buy, Hold, or Sell Right Now?
A structured look at the bull case, the risks, and the most recent earnings execution for LRCX before you decide whether to buy, hold, or sell.
Current setup
LRCX beat estimates last quarter. Below are the key reasons analysts remain constructive and the risks that could change that view.
Bull Case
What keeps the long thesis intact
- Analyst Upgrades and Price TargetsMultiple analysts have upgraded LRCX, with price targets as high as $330, and a consensus 'Strong Buy' rating among 43 analysts with a median target of $315, suggesting a 26.6% upside from $248.75.
- Robust Market PositionInstitutional ownership is high at approximately 84.61%, reflecting strong investor confidence in Lam Research's market position.
- AI-Driven Demand GrowthThe semiconductor sector is benefiting from AI-driven demand, with advanced packaging expected to grow over 40% in 2026, positioning LRCX favorably.
- Strong Financial MetricsLRCX reported trailing twelve-month revenue of $21.68 billion and a profit margin of 30.9%, with a quarter-over-quarter revenue growth of +23.8%.
- Best-in-Class Equipment FranchiseLam Research is recognized for its improved business quality and expanded addressable market, indicating potential for market share gains.
Wall Street rates LRCX buy, giving the bull case institutional backing from 50 analysts.
Watch Out For
What can break the setup quickly
- Valuation ConcernsAnalysts warn LRCX may be overvalued, with a DCF analysis suggesting a fair value around $205.96 compared to the last closing price of $248.75.
- Cyclicality of Semiconductor IndustryThe semiconductor industry is cyclical, and a slowdown in wafer fab spending could lead to a rapid reset of earnings for LRCX.
- Geopolitical Risks Impacting RevenueU.S. 'affiliate rules' are projected to impact revenue by approximately $600 million in 2026, increasing geopolitical risks.
- China Revenue Concentration RisksChina accounted for about 34% of total revenue in FY 2025, with a decline to less than 30% projected for 2026 due to U.S. regulations.
- Expected Margin CompressionA sequential decrease in gross margin is anticipated due to customer mix and tariffs, potentially leading to multiple compression.
- Historical Stock VolatilityLRCX has a history of sharp declines, with drops exceeding 30% during past market downturns, indicating potential risk.
Watch whether new negative commentary on LRCX points to these structural risks or is simply reacting to short-term price moves.
LRCX Earnings Reaction — What the Last Quarter Showed
Last Quarter
- EPS
- $1.47 vs $1.36 est.Beat 8.1%
- Revenue
- $5.8B vs $5.8B est.Beat 1.6%
Full LRCX Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Should I Buy LRCX Right Now?
Bull case, key risks, Wall St analyst verdict, and what council investors are saying — updated daily.
See LRCX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LRCX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare with Peers
Compare business quality, growth, and profitability against top sector peers.
Start ComparisonLRCX — Frequently Asked Questions
Quick answers to the most common questions about buying LRCX stock.
Should I buy LRCX stock right now?
Verdict
LRCX appears fairly valued near today's $297.17 — the consensus rating is "Buy" with a $291 target (-2.2%). The council of high-follower analysts on X is currently signalling bearish. This is informational only — verify the data and consider your own risk tolerance before deciding.
Is now a good time to buy LRCX?
Timing
Timing depends on your horizon, but the data signals are: consensus rating "Buy" with -2.2% upside to the $291 target. In the past 30 days, 11 of 13 covering analysts raised their price targets — a bullish signal.
What is the price target for LRCX stock?
Price Target
LRCX's consensus 12-month price target is $291, set by 50 Wall Street analysts. The bull case high is $385 and the bear case low is $200. From the current price of $297.17, this implies -2.2% upside.
Is LRCX overvalued or undervalued?
Valuation
LRCX appears fairly valued — the $291 consensus target is roughly in line with today's $297.17 (-2.2%). It trades at a forward P/E of 52.6x. Targets range from $200 (bear) to $385 (bull), reflecting different assumptions about growth and margins.
Should I buy LRCX before earnings?
Earnings
LRCX reports next quarter. Earnings-week moves are volatile — historically, analyst targets revise upward after a beat and downward after a miss. The current consensus is "Buy" with a $291 target. Consider position sizing rather than going all-in pre-print.
What are analysts saying about LRCX stock?
Coverage
Of 50 analysts covering Lam Research Corporation (LRCX): 0 Strong Buy, 38 Buy, 11 Hold, 1 Sell, 0 Strong Sell — a "Buy" consensus. The 12-month price target is $291 (range $200–$385). Bullish analysts outnumber bearish by more than 2-to-1.
What are the risks of buying LRCX stock?
Risks
1 of the 50 analysts covering LRCX rate it Sell or Strong Sell. Common concerns include valuation stretch, slowing growth, and sector-specific headwinds — see the Bull vs. Risk cards above for the specific theses on Lam Research Corporation.
This page is for informational purposes only and does not constitute financial advice. Always conduct your own research before investing.